Current assets cover short-term debt more than twice. Quick ratio 16.22×. 2024 was 5.13×.
Opening company
COMPANY OVERVIEW
Opening company
Org. no. 984 041 322·Aksjeselskap
Salg av helsetjenester, medisinsk forskning, utvikling av medisinsk utstyr og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak.
Looking up the company website
Register details are shown now. Website, social and contact listings fill in as they are found.
normedisin@gmail.comBrønnøysundregistrene email
Checking public listings
Company contact from public listings — not a verified direct line to an executive.
Loading annual accounts
Officially registered management, board members and other roles. Each person is looked up by name on 1881 and Gulesider. A number is shown when that listing, Proff or the company website matches this person.
Org. no. 984 041 322·Aksjeselskap
Salg av helsetjenester, medisinsk forskning, utvikling av medisinsk utstyr og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak.
Not found
No website was listed in the registry, Proff, 1881 or Gulesider. Name search and likely domains did not return a page that belongs to this organisation.
normedisin@gmail.comBrønnøysundregistrene email
Company contact from public listings — not a verified direct line to an executive.
Officially registered management, board members and other roles. Each person is looked up by name on 1881 and Gulesider. A number is shown when that listing, Proff or the company website matches this person.
Current assets cover short-term debt more than twice. Quick ratio 16.22×. 2024 was 5.13×.
Equity is a large share of total assets. 2024 was 94%.
The operating margin is high.
Calculated from the annual accounts filed with Brønnøysundregistrene. These bands describe the filed figures. They are not a credit rating. Changes are against the 2024 filing.